Jim Simons Axogen, Inc. Transaction History

Renaissance Technologies LLC

$63.6 Billion
Q1 2024

A detailed history of Jim Simons (Renaissance Technologies LLC) transactions in Axogen, Inc. stock. As of the latest transaction made, Renaissance Technologies LLC holds 87,600 shares of AXGN stock, worth $634,224. This represents 0.0% of its overall portfolio holdings.

Number of Shares

87,600

Previous 108,600 19.34%

Holding current value

$634,224

Previous $742,000 4.72%

% of portfolio

0.0%

Previous 0.0%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	SELL	$6.63 - $10.69 $139,230 - $224,490	-21,000 Reduced 19.34%	87,600 $707,000
Q4 2023 Feb 13, 2024	BUY	$3.61 - $7.76 $392,046 - $842,736	108,600 New	108,600 $742,000
Q2 2023 Aug 11, 2023	BUY	$8.5 - $10.38 $232,050 - $283,374	27,300 New	27,300 $249,000
Q4 2022 Feb 13, 2023	BUY	$9.44 - $13.09 $52,864 - $73,304	5,600 Added 56.0%	15,600 $156,000
Q3 2022 Nov 14, 2022	SELL	$8.14 - $12.25 $95,238 - $143,325	-11,700 Reduced 53.92%	10,000 $119,000

Q2 2022 Aug 12, 2022	SELL	$6.99 - $10.0 $784,278 - $1.12 Million	-112,200 Reduced 83.79%	21,700 $178,000
Q1 2022 May 13, 2022	BUY	$7.26 - $10.7 $972,114 - $1.43 Million	133,900 New	133,900 $1.06 Million
Q3 2021 Nov 12, 2021	SELL	$15.23 - $21.72 $680,781 - $970,884	-44,700 Closed	0 $0
Q2 2021 Aug 13, 2021	BUY	$17.8 - $23.5 $578,500 - $763,750	32,500 Added 266.39%	44,700 $966,000
Q1 2021 May 13, 2021	SELL	$17.18 - $22.6 $187,262 - $246,340	-10,900 Reduced 47.19%	12,200 $247,000
Q4 2020 Feb 10, 2021	SELL	$11.5 - $17.96 $439,300 - $686,072	-38,200 Reduced 62.32%	23,100 $413,000
Q3 2020 Nov 13, 2020	SELL	$10.62 - $13.12 $2.96 Million - $3.65 Million	-278,507 Reduced 81.96%	61,300 $713,000
Q2 2020 Aug 13, 2020	BUY	$7.35 - $10.81 $1.41 Million - $2.07 Million	191,507 Added 129.13%	339,807 $3.14 Million
Q1 2020 May 14, 2020	BUY	$8.38 - $17.34 $1.04 Million - $2.16 Million	124,600 Added 525.74%	148,300 $1.54 Million
Q4 2019 Feb 13, 2020	SELL	$11.18 - $18.6 $1.06 Million - $1.76 Million	-94,400 Reduced 79.93%	23,700 $424,000
Q3 2019 Nov 13, 2019	BUY	$12.09 - $20.46 $1.43 Million - $2.42 Million	118,100 New	118,100 $1.47 Million
Q1 2019 May 14, 2019	SELL	$14.62 - $22.13 $3.73 Million - $5.65 Million	-255,300 Closed	0 $0
Q4 2018 Feb 13, 2019	BUY	$17.09 - $38.25 $4.36 Million - $9.77 Million	255,300 New	255,300 $5.22 Million

Others Institutions Holding AXGN

# of Institutions

125

Shares Held

34.1M

Call Options Held

80.7K

Put Options Held

3.3K

View Full List

About Axogen, Inc.

Ticker AXGN
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 42,283,700
Market Cap $306M
Description
AxoGen, Inc., together with its subsidiaries, develops and markets surgical solutions for physical damage or transection to peripheral nerves. The company's products include Avance Nerve Graft, a biologically active off-the-shelf processed human nerve allograft for bridging severed nerves without the comorbidities associated with a second surgic...

More about AXGN

Track Jim Simons's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Renaissance Technologies LLC, based on Form 13F filings with the SEC.

News

Stay updated on Renaissance Technologies LLC and Jim Simons with notifications on news.

Account